Search

Your search keyword '"Boston Scientific Corp. -- Product development"' showing total 312 results
Start Over Descriptor "Boston Scientific Corp. -- Product development"
312 results on '"Boston Scientific Corp. -- Product development"'

1. Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Patient compliance, Anticoagulants (Medicine), Atrial fibrillation -- Risk factors, Medical equipment and supplies industry -- Product development, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. Key findings from the study [...]

Published
2024

2. Boston Scientific WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Patient compliance, Anticoagulants (Medicine), Atrial fibrillation, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and CHICAGO, Nov. 16, [...]

Published
2024

3. ACURATE neo2tm Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Heart valve diseases, General interest, News, opinion and commentary
Abstract

MARLBOROUGH, Mass. and WASHINGTON: Boston Scientific Corporation has issued the following news release: Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE [...]

Published
2024

4. ACURATE neo2(TM) Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Aortic valve stenosis, Business, News, opinion and commentary
Abstract

MARLBOROUGH, Mass. and WASHINGTON, Oct. 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which evaluated [...]

Published
2024

5. Boston Scientific begins AVANT GUARD trial to evaluate Farapulse PFA System to treat persistent atrial fibrillation

Subjects
Boston Scientific Corp. -- Product development, Atrial fibrillation -- Care and treatment, Anti-arrhythmia drugs -- Product development, Electric fields, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the Farapulse Pulsed Field Ablation (PFA) System as a first-line treatment for persistent [...]

Published
2023

6. Boston Scientific reports 'positive' 12-month results from AGENT IDE trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Transluminal angioplasty, Business, News, opinion and commentary
Abstract

Boston Scientific announced 'positive' 12-month results from the pivotal AGENT IDE clinical trial of the AGENT Drug-Coated Balloon, or DCB. Primary endpoint findings from this first clinical trial in the [...]

Published
2023

7. BIDMC-LED TRIAL LEADS TO FDA APPROVAL OF CORONARY DRUG-COATED BALLOONS

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Light-emitting diodes -- Product development, Medical centers, Cardiology, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Drug approval, Clinical trials, Cardiac patients, Transluminal angioplasty, News, opinion and commentary, Beth Israel Deaconess Medical Center
Abstract

BOSTON, MA -- The following information was released by Beth Israel Deaconess Medical Center (BIDMC): First-of-its-kind Trial in US Shows Drug-coated Balloons are a Superior Treatment Option for Patients Undergoing [...]

Published
2024

8. Feinstein Institutes implants modular CRM system in patient to be enrolled in Boston Scientific MODULAR ATP clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Customer relationship management, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Clinical trials, Research institutes, Customer relationship management software, Customer relationship management, Pharmaceuticals and cosmetics industries
Abstract

Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm [...]

Published
2022

9. Boston Scientific initiates AVANT GUARD clinical trial to evaluate FARAPULSE Pulsed Field Ablation System

Subjects
Boston Scientific Corp. -- Product development, Atrial fibrillation, Anti-arrhythmia drugs -- Product development, Electric fields, Clinical trials, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line treatment for [...]

Published
2023

10. Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE(TM) Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation -- Drug therapy, Anti-arrhythmia drugs -- Product development, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Electric fields, Clinical trials, Business, News, opinion and commentary
Abstract

MARLBOROUGH, Mass., Dec. 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE(TM) Pulsed Field [...]

Published
2023

11. Boston Scientific AGENTtm Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Cardiac patients, Transluminal angioplasty, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has issued the following news release: Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal AGENT IDE clinical trial of the AGENTtm [...]

Published
2023

12. Boston Scientific AGENT(TM) Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Transluminal angioplasty, Business, News, opinion and commentary
Abstract

Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB MARLBOROUGH, Mass. and SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- [...]

Published
2023

13. BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Medical centers, Cardiology, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Drug approval, Clinical trials, Cardiac patients, Transluminal angioplasty, Business, Health, Health care industry, Beth Israel Deaconess Medical Center
Abstract

2024 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- BOSTON - In the largest randomized clinical trial and first [...]

Published
2024

14. Researchers at Duke University Medical Center Have Published New Data on Peripheral Artery Disease (Diversity in randomized clinical trials for peripheral artery disease: a systematic review)

Subjects
Boston Scientific Corp. -- Product development, Medical research -- Reports, Medicine, Experimental -- Reports, Medical centers -- Reports -- Research, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials -- Research -- Reports, Health, Duke University. Hospital -- Reports
Abstract

2024 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on peripheral artery disease is the subject of a new report. [...]

Published
2024

15. Recent Findings in Peripheral Artery Disease Described by Researchers from Boston Scientific (Diversity In Clinical Trial Inclusion for Peripheral Artery Disease Lower Extremity Endovascular Interventions: a Systematic)

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiovascular diseases, Health
Abstract

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in Cardiovascular Diseases and Conditions - Peripheral Artery Disease. According to [...]

Published
2024

16. Boston Scientific announces results from PROTECTED TAVR clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL Cerebral Protection System, which is designed to capture and remove embolic debris stemming from transcatheter aortic [...]

Published
2022

17. Boston Scientific AGENT[TM] Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Transluminal angioplasty, Health
Abstract

2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Boston Scientific Corporation (NYSE: BSX) announced positive 12-month results from the pivotal AGENT IDE clinical [...]

Published
2023

18. Researchers at Beth Israel Deaconess Medical Center Have Reported New Data on Clinical Trials and Studies (Effect of Intensive Versus Limited Monitoring On Clinical Trial Conduct and Outcomes: a Randomized Trial)

Subjects
AstraZeneca PLC -- Product development, Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers -- Research, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials -- Research, Physical fitness -- Research, Pharmaceutical industry -- Product development, Health, Beth Israel Deaconess Medical Center
Abstract

2022 JAN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Clinical Research - Clinical Trials and Studies. [...]

Published
2022

19. Boston Scientific reports 'positive' trial data for Ranger Drug-Coated Balloon

Subjects
Boston Scientific Corp. -- Product development, Business, News, opinion and commentary
Abstract

Boston Scientific announced positive results for the Ranger Drug-Coated Balloon during a late-breaking clinical trial presentation at the Vascular InterVentional Advances meeting in Las Vegas. The data included two- year [...]

Published
2021

20. Boston Scientific announces results from Ekosonic System clinical trial

Subjects
Boston Scientific Corp. -- Product development, Pulmonary embolism, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific announced positive results for the EkoSonic Endovascular System during a late-breaking clinical trial presentation at the Vascular InterVentional Advances, or VIVA, meeting in Las Vegas. Data from the [...]

Published
2021

21. MEP Aids Medical Device Manufacturers: Many medical device companies have benefitted from the Hollings Manufacturing Extension Partnership

Author

Sprovieri, John

Subjects
Johnson & Johnson -- Product development, Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Physiological apparatus -- Product development, Pharmaceutical industry -- Product development, Business, Engineering and manufacturing industries
Abstract

Bringing a medical device to market is a daunting prospect for even the largest manufacturers. There's nurturing a concept from prototype to finished product; determining how and where to manufacture [...]

Published
2018

22. Boston Scientific's EPOCH trial of TheraSphere Y-90 Glass Microspheres to treat metastatic colorectal cancer meets primary and secondary endpoints

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Metastasis -- Care and treatment, Colorectal cancer -- Care and treatment, Medical equipment and supplies industry -- Product development, Liver, Chemotherapy, Cancer -- Chemotherapy, Radiotherapy, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation announced the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) successfully met both primary endpoints, including progression-free survival (PFS) and hepatic progression-free survival (hPFS) [...]

Published
2021

23. Boston Scientific announces data from the EPOCH trial of TheraSphere Y-90

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Colorectal cancer, Medical equipment and supplies industry -- Product development, Liver cancer, Chemotherapy, Cancer -- Chemotherapy, Business, News, opinion and commentary
Abstract

Boston Scientific announced the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres 'successfully met both primary endpoints,' including progression-free survival, or PFS, and hepatic progression-free survival, hPFS, of patients [...]

Published
2021

24. Boston begins enrollment in HI-PEITHO trial for EkoSonic Endovascular System for treatment of acute, intermediate-high-risk pulmonary embolism

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers, Medical test kit industry -- Product development, Pulmonary embolism -- Care and treatment, Medical equipment and supplies industry -- Product development, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the [...]

Published
2021

25. Boston Scientific reports 'positive' results from PINNACLE FLX clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific announced positive 24-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure Device for patients with [...]

Published
2021

26. Feinstein Institutes, Northwell electrophysiologist successfully implant first modular cardiac rhythm management system in novel clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Clinical trials, Research institutes, Customer relationship management software, Business, Business, international
Abstract

MANHASSET, N.Y. -- Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a [...]

Published
2022

27. Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL(TM) Cerebral Protection System

Subjects
Boston Scientific Corp. -- Product development, Stroke (Disease) -- Risk factors, Data security, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Data security issue, Business, News, opinion and commentary
Abstract

Results from largest randomized TAVR trial to date presented at TCT 2022 MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR [...]

Published
2022

28. New Clinical Trials and Studies Findings from University of North Carolina Described (Clip Closure Does Not Reduce Risk of Bleeding After Resection of Large Serrated Polyps: Results From a Randomized Trial)

Subjects
Boston Scientific Corp. -- Product development, Oncology, Experimental -- Reports, Polyps (Pathology) -- Research -- Risk factors, Medical test kit industry -- Product development, Colorectal cancer -- Research -- Risk factors, Medical equipment and supplies industry -- Product development, Clinical trials -- Research -- Reports, Cancer -- Research, Health, University of North Carolina -- Reports
Abstract

2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Clinical Research - Clinical Trials and Studies are discussed in [...]

Published
2023

29. New Clinical Trial Research Findings from Henry Ford Hospital Described (Comparative Analysis of Patient Characteristics In Chronic Total Occlusion Revascularization Studies Trials Vs Real-world Registries)

Subjects
Siemens AG -- Product development, Boston Scientific Corp. -- Product development, Medical research -- Comparative analysis, Medicine, Experimental -- Comparative analysis, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Electronics industry -- Product development, Clinical trials -- Research -- Comparative analysis, Transluminal angioplasty -- Research -- Comparative analysis, Electronics industry, Health, Henry Ford Hospital
Abstract

2022 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in Clinical Trial Research. According to news reporting from [...]

Published
2022

30. Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL[TM] Cerebral Protection System

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Stroke (Disease) -- Risk factors, Data security, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Physiological apparatus -- Product development, Data security issue, Health, Health care industry
Abstract

2022 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR [...]

Published
2022

31. Investigators at London School of Hygiene and Tropical Medicine Discuss Findings in Cardiology (Statistical Appraisal of 6 Recent Clinical Trials In Cardiology Jacc State-of-the-art Review)

Subjects
Pfizer Inc. -- Product development, Bristol-Myers Squibb Co. -- Product development, Novartis AG -- Product development, AstraZeneca PLC -- Product development, Boston Scientific Corp. -- Product development, Bayer AG -- Product development, Clinical trials -- Health aspects -- Research, Physical fitness -- Health aspects -- Research, Medical equipment industry -- Product development -- Health aspects -- Research, Cardiology -- Health aspects -- Research, Hygiene -- Health aspects -- Research, Medical research -- Health aspects, Pharmaceutical industry -- Product development -- Health aspects -- Research, Obesity, Biosensors, Conferences and conventions, Medical equipment, Detection equipment, Editors, Health
Abstract

2019 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Health and Medicine - Cardiology. According to [...]

Published
2019

32. Investigators from Ohio State University Zero in on Clinical Trial Research (Process Mapping Strategies To Prevent Subcutaneous Implantable Cardioverter-defibrillator Infections)

Subjects
Boston Scientific Corp. -- Product development, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Medical equipment and supplies industry -- Product development, Infection -- Research -- Prevention, Clinical trials -- Health aspects -- Research, Defibrillators -- Product development, Health, Health care industry
Abstract

2022 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Research findings on Clinical Trial Research are discussed in a new [...]

Published
2022

33. Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM System

Subjects
Boston Scientific Corp. -- Product development, Customer relationship management, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Medical equipment and supplies industry -- Product development, Heart, Customer relationship management software, Customer relationship management, Telecommunications industry
Abstract

Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM Modular Therapy System. The mCRM System consists of [...]

Published
2021

34. Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM System

Subjects
Boston Scientific Corp. -- Product development, Customer relationship management, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Medical equipment and supplies industry -- Product development, Customer relationship management software, Customer relationship management, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has issued the following news release: Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of [...]

Published
2021

35. Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM System

Subjects
Boston Scientific Corp. -- Product development, Customer relationship management, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Medical equipment and supplies industry -- Product development, Customer relationship management software, Customer relationship management, Business, News, opinion and commentary
Abstract

Trial studying communication between cardiac rhythm management devices aims to expand treatment options for patients who require an ICD MARLBOROUGH, Mass., Dec. 2, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: [...]

Published
2021

36. SIO Announces ACCLAIM Clinical Trial with Ground Breaking Support from Industry Partners

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Metastasis, Medical equipment and supplies industry -- Product development, Liver, Clinical trials, Business, News, opinion and commentary
Abstract

WASHINGTON, Nov. 18, 2021 /PRNewswire/ -- The Society of Interventional Oncology (SIO) announces the launch of the society's first clinical trial, 'Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective [...]

Published
2021

37. Positive Late-breaking Clinical Trial Data for the EkoSonic Endovascular System Presented at VIVA21

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Pulmonary embolism, Medical equipment and supplies industry -- Product development, Clinical trials, Evidence-based medicine, General interest, News, opinion and commentary
Abstract

LAS VEGAS and MARLBOROUGH: Boston Scientific Corporation has issued the following news release: Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic Endovascular System (EKOS system) during a [...]

Published
2021

38. Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger Drug-Coated Balloon

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, General interest, News, opinion and commentary
Abstract

LAS VEGAS: Boston Scientific Corporation has issued the following news release: Today, Boston Scientific (NYSE: BSX) announced positive results for the Ranger Drug-Coated Balloon (DCB) during a late-breaking clinical trial [...]

Published
2021

39. Positive Late-breaking Clinical Trial Data for the EkoSonic(TM) Endovascular System Presented at VIVA21

Subjects
Boston Scientific Corp. -- Product development, Respiratory agents, Pulmonary embolism, Clinical trials, Evidence-based medicine, Business, News, opinion and commentary
Abstract

Analysis found no intracerebral hemorrhages, low major bleeding rates; registry represents largest data set in interventional treatment of pulmonary embolism LAS VEGAS and MARLBOROUGH, Mass., Oct. 5, 2021 /PRNewswire/ -- [...]

Published
2021

41. Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic Endovascular System

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers -- Research, Medical test kit industry -- Product development, Pulmonary embolism -- Research -- Care and treatment, Medical equipment and supplies industry -- Product development, Clinical trials -- Research, Business, international, Law
Abstract

Boston Scientific Corporation (NYSE: BSX) has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center [...]

Published
2021

42. Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(TM) Endovascular System

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers, Medical test kit industry -- Product development, Respiratory agents, Pulmonary embolism -- Care and treatment, Anticoagulants (Medicine), Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Study is first to compare interventional therapy in combination with anticoagulation to anticoagulation alone for treatment of pulmonary embolism MARLBOROUGH, Mass., Aug. 4, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: [...]

Published
2021

43. Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX Left Atrial Appendage Closure Device

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Atrial fibrillation, Medical equipment and supplies industry -- Product development, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has issued the following news release: Today, Boston Scientific (NYSE: BSX) announced positive 24-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy [...]

Published
2021

44. Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX(TM) Left Atrial Appendage Closure Device

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Atrial fibrillation, Medical equipment and supplies industry -- Product development, Business, News, opinion and commentary
Abstract

PINNACLE FLX study meets 24-month endpoint, reinforces positive 12-month outcomes with next-generation device for patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., July 21, 2021 /PRNewswire/ -- Today, Boston Scientific (NYSE: [...]

Published
2021

45. Mon Health in clinical trial to help stop strokes

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation -- Prevention, Medical centers, Medical equipment industry -- Product development, Cardiac patients, Stroke -- Prevention, Fibrillation, Business, General interest, Business, regional
Abstract

Byline: Suzanne Elliott Feb. 18-- Feb. 18--WATCHMAN FLX designed to prevent movement of clots Mon Health Medical Center was tapped by Boston Scientific, a developer of a device that reduces [...]

Published
2020

46. Vagus Nerve Stimulators (VNS) Device Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical research -- Reports, Medicine, Experimental -- Reports, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials -- Reports, Physiological apparatus -- Product development, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2020' report has been added to ResearchAndMarkets.com's offering 'Vagus Nerve [...]

Published
2021

47. Vagus Nerve Stimulators (VNS) Device Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials - ResearchAndMarkets.com

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical research -- Reports, Medicine, Experimental -- Reports, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials -- Reports, Physiological apparatus -- Product development, Business, Business, international
Abstract

DUBLIN -- The 'Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2020' report has been added to ResearchAndMarkets.com's offering. 'Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2020' [...]

Published
2021

48. Vagus Nerve Stimulators (VNS) Device Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical research -- Reports, Medicine, Experimental -- Reports, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials -- Reports, Physiological apparatus -- Product development, Business, Business, international
Abstract

M2 PRESSWIRE-April 14, 2021-: Vagus Nerve Stimulators (VNS) Device Pipeline Assessment Report 2020: Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials (C)1994-2021 M2 COMMUNICATIONS RDATE:14042021 The [...]

Published
2021

49. Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has issued the following press release: Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) - [...]

Published
2021

50. Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) - a type of radioembolization comprised of millions of microscopic glass beads [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results